SLS Stock Analysis: Buy, Sell, or Hold?
SLS - SELLAS Life Sciences Group, Inc. Common Stock
$8.23
-0.81 (-8.96%)
βΌ
5d:
-11.6%
30d:
+59.81%
90d:
+48.82%
WAIT
LOW Confidence
Analysis Updated: Jun 5, 2026 12:00 AM ET
Earnings: May 19, 2026
0d
Smart Money Accumulation
None View Scanner →
Strength: 9.6/10
Get Alerted When SLS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
89 traders called SLS this week
86% bullish • 23 bearish
86% bullish • 23 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: SLS is down 11.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: SLS is down 11.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: SLS is currently trading at $8.23, which is considered slightly high relative to its 30-day fair value range of $5.16 to $8.50.
Technical Outlook: Technically, SLS is in a strong uptrend. Immediate support is located at $7.35, while resistance sits at $9.51. Short-term momentum is weak, with the stock down 9.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+21.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SLS is in a strong uptrend. Immediate support is located at $7.35, while resistance sits at $9.51. Short-term momentum is weak, with the stock down 9.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+21.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$5.16 -
$8.50
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.6%
Protect Your Profits
Holding SLS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.0%)
- BULLISH: Trading 21.5% below Wall St target ($10.00)
- WARNING: Recommendation downgraded due to -11.6% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$5.16 -
$8.50
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$7.35
Resistance Level
$9.51
Current Trend
Strong Uptrend
Technical data as of
Jun 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-54.87
Wall Street Target
$10.00
(+21.5%)
Revenue Growth (YoY)
-82.5%
Share & Embed Analysis
Last updated: June 06, 2026 5:25 AM ET
Data refreshes hourly during market hours. Next update: 6:25 AM
Data refreshes hourly during market hours. Next update: 6:25 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 58 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 61 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix TherapeuticsΒ Inc |
STRONG BUY
18 analysts |
$30 | 57 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 59 HOLD |
Advanced SLS Option Strategies
Professional options setups generated by AI based on today's SLS price and gamma walls.